Development of Adamantan-1-yl-methoxy-Functionalized 1-Deoxynojirimycin Derivatives as Selective Inhibitors of Glucosylceramide Metabolism in Man
β Scribed by Wennekes, Tom; van den Berg, Richard J. B. H. N.; Donker, Wilma; van der Marel, Gijsbert A.; Strijland, Anneke; Aerts, Johannes M. F. G.; Overkleeft, Herman S.
- Book ID
- 115493269
- Publisher
- American Chemical Society
- Year
- 2007
- Tongue
- English
- Weight
- 333 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0022-3263
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea 14a (AR9281), a potent and selective soluble epoxide hydrolase inhibitor, was recently tested in a phase 2a clinical setting for its effectiveness in reducing blood pressure and improving insulin resistance in pre-diabetic patients. In a mouse model
## Abstract The synthesis of the clinical candidate (I) and its analogues is achieved via a library approach allowing the facile preparation of various left hand side and right hand side combinations around the piperidinyl urea nucleus.